Apellis Pharmaceuticals, Inc. (APLS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 192.01M | 199.91M | 458.58M | 178.49M | 166.8M | 212.53M | 196.83M | 199.69M | 172.32M | 146.38M | 110.4M | 94.97M |
| Revenue Growth % | 15.12% | -5.94% | 132.98% | -10.61% | -3.21% | 45.19% | 78.29% | 110.26% | 284.26% | 545.89% | 400.54% | 481.85% |
| Cost of Goods Sold | 40.55M | 29.72M | 24.53M | 14.07M | 34.36M | 40.86M | 33.56M | 23.55M | 20.65M | 19.91M | 22.41M | 8.38M |
| COGS % of Revenue | 21.12% | 14.87% | 5.35% | 7.88% | 20.6% | 19.22% | 17.05% | 11.79% | 11.98% | 13.6% | 20.3% | 8.82% |
| Gross Profit | 151.46M | 170.19M | 434.05M | 164.42M | 132.44M | 171.67M | 163.27M | 176.14M | 151.67M | 126.47M | 87.99M | 86.59M |
| Gross Margin % | 78.88% | 85.13% | 94.65% | 92.12% | 79.4% | 80.78% | 82.95% | 88.21% | 88.02% | 86.4% | 79.7% | 91.18% |
| Gross Profit Growth % | 14.37% | -0.86% | 165.84% | -6.65% | -12.68% | 35.75% | 85.56% | 103.41% | 309.51% | 540.72% | 325.58% | 433.19% |
| Operating Expenses | 201.28M | 221.34M | 210.86M | 197.71M | 215.76M | 197.84M | 210.55M | 205.58M | 213.76M | 210.98M | 225.07M | 207.03M |
| OpEx % of Revenue | 104.83% | 110.72% | 45.98% | 110.76% | 129.36% | 93.09% | 106.97% | 102.95% | 124.05% | 144.14% | 203.87% | 218% |
| Selling, General & Admin | 124.32M | 147.1M | 142.68M | 130.69M | 129.34M | 121.48M | 121.98M | 127.63M | 129.06M | 141.7M | 145.65M | 111.37M |
| SG&A % of Revenue | 64.75% | 73.58% | 31.11% | 73.22% | 77.55% | 57.16% | 61.97% | 63.92% | 74.89% | 96.81% | 131.93% | 117.27% |
| Research & Development | 76.96M | 74.23M | 68.19M | 67.02M | 86.42M | 76.35M | 88.57M | 77.95M | 84.7M | 69.28M | 79.42M | 95.66M |
| R&D % of Revenue | 40.08% | 37.13% | 14.87% | 37.54% | 51.81% | 35.93% | 45% | 39.03% | 49.15% | 47.33% | 71.94% | 100.73% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 26.47M | -51.14M | 223.18M | -33.29M | -83.33M | -26.16M | -47.28M | -29.44M | -62.09M | -84.52M | -137.08M | -120.44M |
| Operating Margin % | 13.78% | -25.58% | 48.67% | -18.65% | -49.96% | -12.31% | -24.02% | -14.74% | -36.03% | -57.74% | -124.17% | -126.82% |
| Operating Income Growth % | 131.76% | -95.47% | 572.05% | -13.05% | -34.21% | 69.04% | 65.51% | 75.55% | 64.54% | 48.48% | 10.37% | 18.96% |
| EBITDA | 26.47M | -50.81M | 223.52M | -32.84M | -82.88M | -25.72M | -46.82M | -28.99M | -61.65M | -84.03M | -136.68M | -120.03M |
| EBITDA Margin % | 13.78% | -25.42% | 48.74% | -18.4% | -49.69% | -12.1% | -23.79% | -14.52% | -35.77% | -57.41% | -123.8% | -126.39% |
| EBITDA Growth % | 131.93% | -97.59% | 577.38% | -13.26% | -34.45% | 69.39% | 65.74% | 75.84% | 64.71% | 48.65% | 10.42% | 19.05% |
| D&A (Non-Cash Add-back) | 0 | 327K | 339K | 446K | 446K | 447K | 457K | 449K | 444K | 490K | 405K | 410K |
| EBIT | 0 | -47.79M | 227.6M | -30.53M | -80.83M | -24.53M | -44.32M | -28.18M | -59.29M | -79.75M | -132.69M | -114.5M |
| Net Interest Income | 0 | -7.34M | -6.9M | -8.54M | -8.39M | -8.14M | -9.64M | -6.17M | -3.66M | -2.85M | -2.32M | -1.34M |
| Interest Income | 2.91M | 3.5M | 4.38M | 2.61M | 2.66M | 3.4M | 2.89M | 3.18M | 3.3M | 4.55M | 4.99M | 6M |
| Interest Expense | -10.32M | 10.85M | 11.28M | 11.15M | 11.05M | 11.53M | 12.53M | 9.36M | 6.97M | 7.4M | 7.31M | 7.34M |
| Other Income/Expense | -7.32M | -7.5M | -6.87M | -8.4M | -8.56M | -9.9M | -9.57M | -8.1M | -4.16M | -2.63M | -2.92M | -1.4M |
| Pretax Income | 19.15M | -58.64M | 216.32M | -41.69M | -91.88M | -36.07M | -56.85M | -37.54M | -66.25M | -87.15M | -140M | -121.84M |
| Pretax Margin % | 9.97% | -29.33% | 47.17% | -23.35% | -55.09% | -16.97% | -28.88% | -18.8% | -38.45% | -59.54% | -126.82% | -128.3% |
| Income Tax | 496K | 313K | 602K | 466K | 341K | 286K | 592K | 114K | 170K | 1.42M | 233K | 194K |
| Effective Tax Rate % | 2.59% | -0.53% | 0.28% | -1.12% | -0.37% | -0.79% | -1.04% | -0.3% | -0.26% | -1.63% | -0.17% | -0.16% |
| Net Income | 18.66M | -58.95M | 215.72M | -42.15M | -92.22M | -36.35M | -57.45M | -37.66M | -66.42M | -88.58M | -140.24M | -122.04M |
| Net Margin % | 9.72% | -29.49% | 47.04% | -23.61% | -55.29% | -17.11% | -29.19% | -18.86% | -38.55% | -60.51% | -127.03% | -128.5% |
| Net Income Growth % | 120.23% | -62.16% | 475.52% | -11.93% | -38.84% | 58.96% | 59.04% | 69.14% | 62.64% | 46.64% | 26.68% | 21.76% |
| Net Income (Continuing) | 18.66M | -58.95M | 215.72M | -42.15M | -92.22M | -36.35M | -57.45M | -37.66M | -66.42M | -88.58M | -140.24M | -122.04M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.00 | -0.47 | 1.71 | -0.33 | -0.74 | -0.29 | -0.46 | -0.30 | -0.54 | -0.73 | -1.17 | -1.02 |
| EPS Growth % | 100% | -62.07% | 471.74% | -10% | -37.04% | 60.27% | 60.68% | 70.59% | 65.38% | 51.33% | 33.14% | 30.14% |
| EPS (Basic) | 0.00 | -0.47 | 1.71 | -0.33 | -0.74 | -0.29 | -0.46 | -0.30 | -0.54 | -0.73 | -1.17 | -1.02 |
| Diluted Shares Outstanding | 0 | 126.02M | 126.02M | 126.02M | 125.45M | 123.9M | 123.9M | 123.9M | 122.96M | 121.23M | 120.29M | 119.32M |
| Basic Shares Outstanding | 0 | 126.02M | 126.02M | 126.02M | 125.45M | 123.9M | 123.9M | 123.9M | 122.96M | 121.23M | 120.29M | 119.32M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |